PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Flufenamic acid inhibits secondary hemorrhage and BSCB disruption after spinal cord injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30128046 ↗2018Reported benefit

Flufenamic acid inhibits secondary hemorrhage and BSCB disruption after spinal cord injury.

MouseSpinal cord injuryContusionC57BL/6 and Thy1-GFP-MFemalen = Three groups of n=12 animals per group; histological subana…Intraperitoneal injection12.5 mg/kgFirst dose 1 h after spinal cord injury

Model: Moderate contusion spinal cord injury at T10

Flufenamic acid reduced Trpm4 expression, secondary haemorrhage and capillary fragmentation, promoted angiogenesis, suppressed MMP-2 and MMP-9 at 1 day and attenuated blood-spinal cord barrier disruption at 1 and 3 days. It reduced microglia/macrophage activation, produced smaller lesions and less…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.